Curatis Holding AG (SWX:CURN)

Market Cap	86.07M +22.9%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	5.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,496
Average Volume	7,550
Open	16.60
Previous Close	16.05
Day's Range	16.20 - 16.70
52-Week Range	9.14 - 19.90
Beta	n/a
RSI	62.69
Earnings Date	n/a

About Curatis Holding AG

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collage...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Roland Rutschmann
• Employees: 20
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: CURN